DLG4 and cerebral infarction: Studies in rodents and gyrencephalic brain primate models have shown that blocking the signaling of NMDA receptors, postsynaptic density protein 95 (PSD-95), and NO synthase (NOS) has neuroprotective effects during the acute phase of cerebral infarction [97,98].